Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041747 | SCV000065443 | benign | not specified | 2011-11-03 | criteria provided, single submitter | clinical testing | Gln4662Glu in exon 64 of USH2A: This variant is not expected to have clinical si gnificance because it has been identified in dbSNP in 1.8% (91/5013) control chr omosomes (rs41302237). |
Gene |
RCV000828964 | SCV000970672 | benign | not provided | 2018-05-29 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000828964 | SCV001112074 | benign | not provided | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000828964 | SCV001146601 | benign | not provided | 2018-11-12 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003450779 | SCV004183112 | benign | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003450778 | SCV004183114 | benign | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000828964 | SCV005287599 | benign | not provided | criteria provided, single submitter | not provided |